RATIONALE: Noonan syndrome (NS) is an autosomal dominant RASopathy caused by pathogenic variants in genes that regulate the rat sarcoma (RAS)/mitogen-activated protein kinase (MAPK) signaling pathway. Hearing impairment is increasingly recognized as part of the NS phenotype and may include sensorineural hearing loss of varying severity....
✦ The floor
Discussion
Signed responses from readers of the wire.
Audiologists should ensure infants diagnosed with Noonan syndrome receive early audiological assessment, as bilateral profound sensorineural (nerve-related) hearing loss may be part of the presentation.
Linking RAS/MAPK pathway variants to auditory phenotype in Noonan syndrome expands the known spectrum of syndromic hearing loss and may inform genetic counseling and newborn screening protocols.
- 01Single infant with Noonan syndrome presented with bilateral profound sensorineural hearing loss.
- 02RAS/MAPK pathway gene variants are proposed as a mechanism for hearing loss in this syndrome.
- 03Literature review contextualizes hearing loss within the broader Noonan syndrome phenotype.
- 04Raises awareness that hearing loss may be an underrecognized feature of Noonan syndrome.
- 05Early audiological referral for infants with Noonan syndrome is implicated by this report.
Bilateral profound sensorineural hearing loss can be a presenting feature of Noonan syndrome in infancy.
studypartially supportedRAS/MAPK pathway variants are linked to the auditory phenotype in Noonan syndrome.
studyunclear- PMID
- 43063090
- DOI
- 10.1097/MD.0000000000051601.
- Journal
- Medicine
- Publication type
- case_report
- Evidence level
- 4
- Sample size
- 1
- Population
- Infant with Noonan syndrome and bilateral profound sensorineural hearing loss
- Intervention
- Genetic and audiological characterization of Noonan syndrome presentation
Primary outcomes
Description of auditory phenotype in Noonan syndrome; Association of RAS/MAPK variants with hearing loss